Clinical trial
Comparison of Visual Outcomes of Pars Plana Vitrectomy With and Without Injection Clexane for Rhegmatogenous Retinal Detachment Proliferative Vitreoretinopathy
NCT07787377 is registered in ClinicalTrials.gov with Lahore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Visual Outcomes of Pars Plana Vitrectomy With and Without Injection Clexane for Rhegmatogenous Retinal Detachment Proliferative Vitreoretinopathy
- Lead sponsor
- Lahore General Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 1, 2026
- Completion date
- October 30, 2026
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rhegmatogenous retinal detachment with grade c proliferative vitreoretinopathy